ES456279A1 - Un procedimiento para preparar compuestos de cetofosfonato. - Google Patents

Un procedimiento para preparar compuestos de cetofosfonato.

Info

Publication number
ES456279A1
ES456279A1 ES456279A ES456279A ES456279A1 ES 456279 A1 ES456279 A1 ES 456279A1 ES 456279 A ES456279 A ES 456279A ES 456279 A ES456279 A ES 456279A ES 456279 A1 ES456279 A1 ES 456279A1
Authority
ES
Spain
Prior art keywords
carbon atoms
indanyl
pentanorprostaglandins
ketophosphonate
cycloalkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES456279A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES456279A1 publication Critical patent/ES456279A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Un procedimiento para preparar compuestos de cetofosfonato de la estructura: (**formula**) en la que A es cicloalcohilo de tres a diez átomos de carbono, 1-adamantilo, 2-norbornilo, 2-(1,2,3,4-tetrahidronaftilo), 2-indanilo o 2-indanilo sustituido en el que dicho sustituyente en halógeno, trifluorometilo, alcohilo de 1 a 4 átomos de carbono o alcoxi de 1 a 4 átomos de carbono; n es un número entero de 0 a 05; caracterizado por hacer reaccionar un éster alcohilo (de 1 a 4 átomos de carbono).
ES456279A 1972-11-08 1977-11-25 Un procedimiento para preparar compuestos de cetofosfonato. Expired ES456279A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
ES456279A1 true ES456279A1 (es) 1978-11-01

Family

ID=23177829

Family Applications (3)

Application Number Title Priority Date Filing Date
ES420386A Expired ES420386A1 (es) 1972-11-08 1973-11-09 Un procedimiento para preparar un pentanorprostaglandinas.
ES444398A Expired ES444398A1 (es) 1972-11-08 1976-01-16 Un procedimiento para preparar compuestos intermedios de o- mega-pentanorprostaglandinas.
ES456279A Expired ES456279A1 (es) 1972-11-08 1977-11-25 Un procedimiento para preparar compuestos de cetofosfonato.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES420386A Expired ES420386A1 (es) 1972-11-08 1973-11-09 Un procedimiento para preparar un pentanorprostaglandinas.
ES444398A Expired ES444398A1 (es) 1972-11-08 1976-01-16 Un procedimiento para preparar compuestos intermedios de o- mega-pentanorprostaglandinas.

Country Status (20)

Country Link
JP (1) JPS5714347B2 (es)
AT (1) AT345999B (es)
BE (1) BE807046A (es)
CA (1) CA1033727A (es)
CH (1) CH593930A5 (es)
DE (1) DE2355731C3 (es)
DK (1) DK143499C (es)
ES (3) ES420386A1 (es)
FI (1) FI58912C (es)
FR (3) FR2205338B1 (es)
GB (1) GB1456838A (es)
IE (1) IE40043B1 (es)
IL (2) IL43571A (es)
IN (1) IN139265B (es)
NL (1) NL7315307A (es)
NO (2) NO143663C (es)
PH (2) PH13261A (es)
SE (4) SE412229B (es)
SU (2) SU667131A3 (es)
ZA (1) ZA738595B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (de) * 1977-12-03 1979-06-07 Bayer Ag Neue bicycloalkenyl-prostaglandine und verfahren zu ihrer herstellung
EP1021402B1 (en) * 1997-09-09 2005-11-23 Duke University Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
PL339212A1 (en) * 1997-09-09 2000-12-04 Procter & Gamble Aromatic c16-c20-substituted tetrahydroprostaglandines useful as fp agonists
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
JP4834224B2 (ja) * 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
ES2326558T3 (es) * 2007-11-28 2009-10-14 Bauer Maschinen Gmbh Torno.
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (es) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
PH13261A (en) 1980-02-25
IL43571A (en) 1977-08-31
NO144385C (no) 1981-08-19
FR2286147A1 (fr) 1976-04-23
SE417957B (sv) 1981-04-27
SU704456A3 (ru) 1979-12-15
NO143663C (no) 1981-03-25
DE2355731A1 (de) 1974-05-22
NL7315307A (es) 1974-05-10
IE40043B1 (en) 1979-02-28
CA1033727A (en) 1978-06-27
DK143499C (da) 1982-01-11
FR2205338A1 (es) 1974-05-31
AU6230273A (en) 1975-05-08
SE7612261L (sv) 1976-11-03
DE2355731C3 (de) 1981-01-15
GB1456838A (en) 1976-11-24
SU667131A3 (ru) 1979-06-05
FI58912B (fi) 1981-01-30
FR2291200A1 (fr) 1976-06-11
IE40043L (en) 1974-05-08
JPS5714347B2 (es) 1982-03-24
DE2355731B2 (de) 1980-04-30
ES420386A1 (es) 1976-07-01
NO144385B (no) 1981-05-11
JPS49133357A (es) 1974-12-21
PH13320A (en) 1980-03-13
FR2205338B1 (es) 1978-07-13
FR2291200B1 (es) 1979-01-05
AT345999B (de) 1978-10-10
SE412229B (sv) 1980-02-25
ATA941073A (de) 1978-02-15
BE807046A (fr) 1974-05-08
NO743616L (no) 1974-05-09
FR2286147B1 (es) 1978-09-22
IL50310A (en) 1977-08-31
SE7612262L (sv) 1976-11-03
CH593930A5 (es) 1977-12-30
IL43571A0 (en) 1974-03-14
IN139265B (es) 1976-05-29
ES444398A1 (es) 1977-12-01
NO143663B (no) 1980-12-15
DK143499B (da) 1981-08-31
SE7701523L (sv) 1977-02-10
ZA738595B (en) 1974-09-25
FI58912C (fi) 1981-05-11

Similar Documents

Publication Publication Date Title
ES456279A1 (es) Un procedimiento para preparar compuestos de cetofosfonato.
ES413639A1 (es) Un procedimiento para la preparacion de un compuesto deri- vado de dopamina.
ES413267A1 (es) Un procedimiento para la preparacion de un derivado de aci-do indenilacetico.
ES389912A1 (es) Un procedimiento para la preparacion de compuestos odoran- tes.
ES464045A1 (es) Un procedimiento para la produccion de una gamma-pirona.
ES383006A1 (es) Un procedimiento para la preparacion de compuestos utiles como agentes neurolepticos.
ES378206A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles.
ES462849A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina.
ES441257A1 (es) Procedimiento para preparar aminocicloles.
ES380390A1 (es) Procedimiento para la preparacion de un compuesto de 5-ni- tro-furil-pirazol.
ES410855A1 (es) Procedimiento para la obtencion de derivados de benzociclo-heptatiofeno.
ES364980A1 (es) Un metodo para preparar nuevos derivados de adamantano.
ES430417A1 (es) Procedimiento para preparar bromuro de amidoalquil-trifenil-fosfonio.
ES411737A1 (es) Procedimiento para la preparacion de compuestos heteroci- clicos binucleares.
ES285790A1 (es) Procedimiento para la producción de succinimidas
ES437041A1 (es) Un procedimiento para preparar derivados de 1-ftalazona.
ES383342A1 (es) Procedimiento para la preparacion de nuevos derivados de labencensulfonamida.
ES385084A1 (es) Un procedimiento para la preparacion de nuevos derivados deacido glucuronico.
ES289751A1 (es) Procedimiento para la obtenciën de granulados minusculos
ES226732A1 (es) Un procedimiento para la preparación de derivados de difenilalcanos y difenilalcenos
ES428624A1 (es) Procedimiento para la preparacion de derivados de la pirimi-dina.
ES461191A1 (es) Un procedimiento para la preparacion de nuevos derivados de arilcarboxamida.
ES320083A1 (es) Procedimiento de preparacion de los derivados de la difenilamina.
ES457688A1 (es) Nuevo procedimiento de obtencion de sales acidas de adicion de 3-fenil-5-dietilamino-etil-1,2-4,-oxodiazol.
ES320802A1 (es) Un procedimiento para la preparaciën de 2- (2'-tiazolin-2'- i1) -bencimidazoles